Adherence to GLP-1 RA therapy may be improved by slowing dose escalation, as per label instructions, and setting patient expectations for possible gastrointestinal adverse outcomes that should subside over time
Furler J, ONeal D, Speight J et al (2017) Supporting insulin initiation in type 2 diabetes in primary care: results of the Stepping Up pragmatic cluster randomised controlled clinical trial
Total Fat: 9g
Common Mistakes You May Commit When Starting GLP 1 Treatment Now, lets look into the typical missteps seen at the start of GLP-1 therapy so you can better understand how to follow the early phase of treatment
14 Concerns remain over the quality and safety of compounded versions.9 Drugmaker giants like Eli Lilly have even filed lawsuits to stop the use of compounded medications
We still have many unanswered questions about ideal dosing, duration, and who benefits most, such as whether APOE4 gene carriers may respond differently